A single-dose skincare pilot is a limited manufacturing run used to assess the proposed formula, container and process before a larger order. Agree what the run must answer, which units will be examined and how the results will be recorded. A box of attractive samples is not, by itself, an approval to scale.
What should pilot run packaging establish?
A formula sample can show texture and appearance without showing how the product fills, seals or dispenses in the retail container. The pilot connects those questions to the intended packaging route. Name which parts of the proposed production setup the pilot represents, and which are still provisional.
For BFS contract manufacturing, that includes the proposed container and opening made during forming, filling and sealing. For preformed or glass packs, identify the container, closure or sealing arrangement separately. A sample made on a different route may answer a development question without representing the final manufacturing process.
Three decisions to make before the run
- Fix the version: identify the formula, container drawing or sample, target fill, opening and intended retail pack. Record anything not yet final.
- Agree the questions and checks: list what will be inspected, which methods and acceptance criteria are proposed, and who reviews the results. Do not add pass/fail limits after seeing the samples.
- Separate technical and commercial decisions: first decide what the evidence supports; then price the confirmed version and its pack-out. A lower unit price does not resolve an open technical question.
Pilot quantity and timing follow from the work agreed with the manufacturing team. They are not universal figures. Where multiple formulas, mould versions or artwork variants are involved, identify which combinations the run actually covers rather than treating one sample as representative of every option.
A practical sequence for reviewing the pilot
Stage-gate for a useful pilot
Gates from the note. Timelines stay in the project file.
- Scope the questionsFormula in the selected container, opening, secondary pack, inspection list.
- Confirm the routeBFS, glass or preformed — a pilot on the wrong path samples the wrong unit.
- Transfer and checksFill, seal and handling on the agreed version. Validation language is project-specific.
- Go / no-goGo means the reviewed unit is the manufacturing version. Quantity talks after that gate.
Use the following sequence as a discussion framework, not as a claim that every product follows one validated protocol:
- Scope review: identify the formula, fill, container, market and intended use. List open questions and the person responsible for each.
- Readiness review: confirm the proposed materials, line arrangement, test plan and sample-identification method before the run.
- Run and record: keep the agreed process observations, sample references and deviations tied to the actual version made.
- Examine filled and packed units: review the agreed checks and the opening, dispensing and pack-out experience. Record what is accepted or needs revision.
- Decision review: proceed with the confirmed scope, run a focused revision, or pause while a material issue is resolved. Document the reason.
Which sample checks belong in the brief?
Select the relevant checks with the technical team. Define their scope and acceptance criteria for the actual formula and container:
- Fill consistency and the amount that can be dispensed through the intended opening.
- Seal or closure integrity, opening effort and any visible container defects.
- Formula appearance and behaviour in the selected contact materials.
- The microbiological, stability and compatibility work agreed for the project, including studies that will continue after the run.
- Fit in the retail carton or tray, unit count, component identification and draft use instructions.
- Retain samples and records that let both teams identify the same pilot version later.
An initial observation is not a completed shelf-life study, and a pilot sample does not establish sterility by appearance. The single-dose quality-control guide explains the different checkpoint categories; the compatibility guide covers formula and container questions.
What should you receive after the pilot?
Agree a handover that both teams can use: identified sample units, the formula and container version, the results of the checks in scope, a record of deviations, unresolved questions and the next decision. List studies still underway separately from completed results.
Before discussing a larger run, confirm whether the proposed production version changes the formula, tool, line arrangement, opening or pack-out. A change may require additional review; do not assume an earlier sample approves a different version. Use the MOQ and quote-comparison guide to define the commercial scope once that version is clear.
Avoid ambiguous approvals
“Sample approved” is incomplete when one team means skin feel and the other means the filled retail pack. Record exactly what was approved and what remains open. Other avoidable gaps include mixing sample versions, omitting the activator or secondary pack from a kit review, and treating provisional observations as final test results.
For a first discussion, share formula status, the intended container and fill, destination market, expected quantity and the questions you need the pilot to answer. Send your pilot brief with undecided items marked as open. The review can then focus on the work needed before production is planned.